|
Absorbable
Polymers
International,
API (formerly:
Birmingham
Polymers
Inc. BPI
+ Absorbable
Polymers
Technologies
APT)
is one of
only a few
companies
worldwide
that manufacture
biodegradable
polymers
for medical
application.
All of their
polymers
are produced
under current
Good Manufacturing
Practices
(cGMP),
and they
maintain
both Drug
and Device
Master Files
with the
FDA.
Since 1987,
API has
been a leader
in the synthesis
of lactide,
glycolide
and e-caprolactone
polymers
(under the
trade name:
Lactel®).
That is
for these
reasons
and for
the excellent
API's fame
that NP
PHARM distributes
their polymers
in the south
of Europe
(France,
Italy, Spain
and Portugal).
That is
why NP PHARM
proposes
in the south
of Europe
their polymers
of high
quality.
API has
commercialized
ten polymers
used in
twelve approved
applications.
Absorbable
Polymers
International
is a wholly
owned subsidiary
of the pharmaceutical
company
Durect
Corporation.
Together
they combine
research,
development
and manufacturing
into a single
team to
help clients
at any stage
of the pharmaceutical
or medical
device development
path.
|
|
